{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:09:47Z","timestamp":1791828587117,"version":"4.3.4"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Institutional Ethics Committee","award":["NK\/4046\/DM"],"award-info":[{"award-number":["NK\/4046\/DM"]}]},{"name":"Clinical Trials Registry of India","award":["CTRI\/2018\/01\/011342"],"award-info":[{"award-number":["CTRI\/2018\/01\/011342"]}]},{"name":"Statistical Analysis Plan"},{"name":"Data Sharing Agreement"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To evaluate the efficacy and safety of a step-down regimen of oral prednisolone over 24\u2009weeks in patients of axial SpA (axSpA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This proof-of-concept double-blind randomized controlled trial enrolled patients with active axSpA (BASDAI \u22654) having predominantly axial disease (\u22641 active joint currently) and inadequate response to NSAIDs. They were randomized to receive either oral prednisolone (n\u2009=\u200932) or placebo (n\u2009=\u200933) at a dose of 60, 40, 30, 20, 15 and 10\u2009mg daily for 1\u2009week each, following which they received 5\u2009mg prednisolone (or placebo) daily for 18\u2009weeks. The primary endpoint was a 50% improvement in the BASDAI (BASDAI50) at week 24. Analysis was intention to treat.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A BASDAI50 was achieved by 12 of 32 patients (37.5%) in the prednisolone arm and 3 of 33 patients (9.1%) in the placebo arm at 24\u2009weeks [difference 28.4% (95% CI 7.9, 46.7)]. However, there was no difference in achieving a 20 or 40% improvement in the Assessment of SpondyloArthritis international Society response between the groups. Although there was a significant intergroup difference in adjusted \u0394BASDAI and \u0394Ankylosing Spondylitis Disease Activity Score with CRP at 24\u2009weeks, there was no difference at 12\u2009weeks. There was also no significant difference in \u0394BASFI, \u0394BAS-G or \u0394BASMI at 12 or 24\u2009weeks. No serious adverse events were noted. There was significant weight gain in the first 12\u2009weeks in the prednisolone group vs placebo [0.9 (s.d. 0.4) kg], but not at 24\u2009weeks.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In this small study, oral prednisolone was efficacious in axSpA in achieving the primary outcome, but many crucial secondary outcomes such as functional improvement were not met. Its impact on bone loss was not studied.<\/jats:p>\n                  <jats:p>Trial registration: CTRI\/2018\/01\/011342.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa685","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T11:09:31Z","timestamp":1601636971000},"page":"1932-1941","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy of a step-down regimen of oral prednisolone in axial spondyloarthritis: result of a double-blind randomized controlled trial (COBRA-AS Study)"],"prefix":"10.1093","volume":"60","author":[{"given":"Debashish","family":"Mishra","sequence":"first","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3626-0694","authenticated-orcid":false,"given":"Varun","family":"Dhir","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9727-044X","authenticated-orcid":false,"given":"G S R S N K","family":"Naidu","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aastha","family":"Khullar","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Postgraduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shefali","family":"Sharma","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0813-1243","authenticated-orcid":false,"given":"Aman","family":"Sharma","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0141-7655","authenticated-orcid":false,"given":"Sanjay","family":"Jain","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,7]]},"reference":[{"key":"2021040620372892200_keaa685-B1","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing spondylitis and axial spondyloarthritis","volume":"374","author":"Taurog","year":"2016","journal-title":"N Engl J Med"},{"key":"2021040620372892200_keaa685-B2","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/acr.22831","article-title":"Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis","volume":"68","author":"Stolwijk","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021040620372892200_keaa685-B3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021040620372892200_keaa685-B4","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/art.41042","article-title":"Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"71","author":"Ward","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2021040620372892200_keaa685-B5","doi-asserted-by":"crossref","first-page":"vi10","DOI":"10.1093\/rheumatology\/key217","article-title":"The current standard of care and the unmet needs for axial spondyloarthritis","volume":"57","author":"Noureldin","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2021040620372892200_keaa685-B6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/rheumatology\/kew367","article-title":"Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis","volume":"56","author":"Baraliakos","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2021040620372892200_keaa685-B7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/1759720X14535512","article-title":"Biological therapies for spondyloarthritis","volume":"6","author":"Bruner","year":"2014","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2021040620372892200_keaa685-B8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/MAJ.0b013e3182514093","article-title":"Economic considerations of the treatment of ankylosing spondylitis","volume":"343","author":"Reveille","year":"2012","journal-title":"Am J Med Sci"},{"key":"2021040620372892200_keaa685-B9","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N Engl J Med"},{"key":"2021040620372892200_keaa685-B10","first-page":"S139","article-title":"Glucocorticoid treatment in spondyloarthritis","volume":"29","author":"Fendler","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"2021040620372892200_keaa685-B11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/ar592","article-title":"Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-\u03b1 therapy and other novel approaches","volume":"4","author":"Braun","year":"2002","journal-title":"Arthritis Res"},{"key":"2021040620372892200_keaa685-B12","doi-asserted-by":"crossref","first-page":"iii40","DOI":"10.1136\/ard.61.suppl_3.iii40","article-title":"Conventional treatments for ankylosing spondylitis","volume":"61","author":"Dougados","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"2021040620372892200_keaa685-B13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/03009749209095085","article-title":"Intravenous methylprednisolone pulse therapy in ankylosing spondylitis","volume":"21","author":"Peters","year":"1992","journal-title":"Scand J Rheumatol"},{"key":"2021040620372892200_keaa685-B14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/annrheumdis-2012-203055","article-title":"Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trial","volume":"73","author":"Haibel","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2021040620372892200_keaa685-B15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(97)01300-7","article-title":"Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis","volume":"350","author":"Boers","year":"1997","journal-title":"Lancet"},{"key":"2021040620372892200_keaa685-B16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021040620372892200_keaa685-B17","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"2021040620372892200_keaa685-B18","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"2021040620372892200_keaa685-B19","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/35.1.66","article-title":"The Bath Ankylosing Spondylitis Patient Global Score (BAS-G)","volume":"35","author":"Jones","year":"1996","journal-title":"Br J Rheumatol"},{"key":"2021040620372892200_keaa685-B20","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s10067-012-2043-z","article-title":"Translation, cultural adaptation, and validation of the Bath questionnaires and HAQ-S in Hindi for Indian patients with ankylosing spondylitis","volume":"31","author":"Dhir","year":"2012","journal-title":"Clin Rheumatol"},{"key":"2021040620372892200_keaa685-B21","first-page":"1694","article-title":"Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index","volume":"21","author":"Jenkinson","year":"1994","journal-title":"J Rheumatol"},{"key":"2021040620372892200_keaa685-B22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","article-title":"Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis","volume":"68","author":"Lukas","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021040620372892200_keaa685-B23","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/ard.2008.104018","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021040620372892200_keaa685-B24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/ard.2003.016386","article-title":"Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis","volume":"63","author":"Rudwaleit","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"2021040620372892200_keaa685-B25","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.2147\/DDDT.S115099","article-title":"Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability","volume":"10","author":"Bandinelli","year":"2016","journal-title":"Drug Des Dev Ther"},{"key":"2021040620372892200_keaa685-B26","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1002\/art.1780240521","article-title":"Intravenous methylprednisolone pulse therapy in severe ankylosing spondylitis","volume":"24","author":"Mintz","year":"1981","journal-title":"Arthritis Rheum"},{"key":"2021040620372892200_keaa685-B27","first-page":"51","article-title":"The effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis","volume":"53","author":"Richter","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"2021040620372892200_keaa685-B28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13075-018-1565-4","article-title":"Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study","volume":"20","author":"Haroon","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2021040620372892200_keaa685-B29","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","article-title":"Oral corticosteroids and fracture risk: relationship to daily and cumulative doses","volume":"39","author":"van Staa","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"2021040620372892200_keaa685-B30","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/rheumatology\/kez025","article-title":"Added value of biomarkers compared with clinical parameters for the prediction of radiographic spinal progression in axial spondyloarthritis","volume":"58","author":"Rademacher","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2021040620372892200_keaa685-B31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40674-016-0055-6","article-title":"Osteoporosis management in ankylosing spondylitis","volume":"2","author":"Hinze","year":"2016","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"2021040620372892200_keaa685-B32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00223-017-0274-3","article-title":"Bone mineral density and fracture risk in ankylosing spondylitis: a meta-analysis","volume":"101","author":"Pray","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"2021040620372892200_keaa685-B33","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00002281-200307000-00013","article-title":"Mechanisms of glucocorticoid-induced osteoporosis","volume":"15","author":"Canalis","year":"2003","journal-title":"Curr Opin Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/4\/1932\/36913302\/keaa685.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/4\/1932\/36913302\/keaa685.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T23:40:20Z","timestamp":1617752420000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/4\/1932\/5960202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,7]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,11,7]]},"published-print":{"date-parts":[[2021,4,6]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa685","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,11,7]]}}}